Showing results (221-230 of 434) with videos related to

Sort By:
Pageof 44
The Journal of Clinical Endocrinology and Metabolism|June 1, 1989
Serum concentration and urinary excretion of the luteinizing hormone-releasing hormone agonist buserelin in patients with endometriosisL Kiesel, J Sandow, K Bertges, et al.
Gynecologic Oncology|December 17, 2010
Hypermethylated DAPK in serum DNA of women with uterine leiomyoma is a biomarker not restricted to cancerNorman Häfner, Herbert Diebolder, Lars Jansen, et al.
Human Reproduction Update|September 1, 1995
Anaerobes in ejaculates of subfertile menW Eggert-Kruse, G Rohr, W Ströck, et al.
Anticancer Research|May 1, 1994
Wild-type p53 suppresses the malignant phenotype in breast cancer cells containing mutant p53 allelesI B Runnebaum, J K Yee, D G Kieback, et al.
Gynecologic Oncology|May 1, 1996
Subcellular localization of accumulated p53 in ovarian cancer cellsI B Runnebaum, D G Kieback, V J Mobus, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 1, 1993
Elevated serum inhibin levels and suppressed luteinizing hormone surge in young patients stimulated with gonadotropinsJ Urbancsek, T Rabe, K Grunwald, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|January 17, 2013
Laparoscopic lymphocele fenestration in gynaecological cancer patients after retroperitoneal lymph node dissection as a first-line treatment optionM P Radosa, H Diebolder, O Camara, et al.
Pageof 44